Literature DB >> 17192536

The antidepressant quandary--considering suicide risk when treating adolescent depression.

Gregory E Simon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17192536     DOI： 10.1056/NEJMp068270

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders.

Authors:  Florence Thibaut; John M W Bradford; Peer Briken; Flora De La Barra; Frank Häßler; Paul Cosyns
Journal:  World J Biol Psychiatry       Date:  2015-11-23       Impact factor: 4.132

2.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

3.  Pediatric antidepressant use after the black-box warning.

Authors:  Susan H Busch; Colleen L Barry
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

4.  Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.

Authors:  Judith R Homberg; Jocelien D A Olivier; Tom Blom; Tim Arentsen; Chantal van Brunschot; Pieter Schipper; Gerdien Korte-Bouws; Gilles van Luijtelaar; Liesbeth Reneman
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial).

Authors:  Cheney J G Drew; Mark Postans; Cateno Petralia; Rachel McNamara; Philip Pallmann; Dave Gillespie; Lisa H Evans; Nils Muhlert; Mia Winter; Khalid Hamandi; William P Gray
Journal:  Pilot Feasibility Stud       Date:  2019-07-06

6.  Transdermal selegiline for the treatment of major depressive disorder.

Authors:  Kelly C Lee; Jack J Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

7.  Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.

Authors:  Christine Y Lu; Fang Zhang; Matthew D Lakoma; Jeanne M Madden; Donna Rusinak; Robert B Penfold; Gregory Simon; Brian K Ahmedani; Gregory Clarke; Enid M Hunkeler; Beth Waitzfelder; Ashli Owen-Smith; Marsha A Raebel; Rebecca Rossom; Karen J Coleman; Laurel A Copeland; Stephen B Soumerai
Journal:  BMJ       Date:  2014-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.